On the record: Thomas H. Kean, Jr., House Committee on Energy and Commerce, and disclosed JNJ trades
Thomas H. Kean, Jr. serves on a committee that oversees health & pharma, and has 2 disclosed JNJ trades on the public record. A timeline, from the filings.
· U.S. Wealth Watcher
Thomas H. Kean, Jr. sits on the House Committee on Energy and Commerce, whose work touches health & pharma. Public periodic transaction reports disclose 2 trades in JNJ since the start of the current Congress. Here is the timeline, taken straight from the filings.
- On June 2, 2026, the report discloses a sale of JNJ worth $1,001 to $15,000, filed July 16, 2026, within the STOCK Act window.
- On June 29, 2026, the report discloses a sale of JNJ worth $1,001 to $15,000, filed July 16, 2026, within the STOCK Act window.
Serving on a committee whose work touches an industry, and trading a stock in that industry, is common and, by law, disclosed. This timeline notes dated public filings and implies nothing about any decision or any motive.
This is an automatically generated timeline of dated public records. It states facts and implies nothing about any decision or motive. Correlation is not causation.
We report from public records and published reporting. Appearing here is not an allegation of wrongdoing.